What test is commonly used to classify a substance as a human carcinogen?

What test is commonly used to classify a substance as a human carcinogen?

• A. Ames test
• B. 2-year rodent bioassay
• C. Acute toxicity test
• D. In vitro cytotoxicity assay

Answer: (B)

Long-term cancer risk assessment relies on observing cancer development in animals, and the standard test used to classify a substance as a human carcinogen is a two-year rodent bioassay. In this study, rats and/or mice are exposed to various doses of the substance over a large portion of their lifespan, and researchers track tumor incidence across multiple organs. This direct evidence of cancer formation in a mammalian system provides the most relevant data for humans and is weighed together with any available human epidemiology. Other tests have important roles but aren’t definitive for carcinogenicity. The Ames test screens for mutagenic potential in bacteria and can flag potential carcinogens, but mutagenicity does not always translate to human carcinogenicity. Acute toxicity tests focus on immediate lethal effects and do not address cancer risk, and in vitro cytotoxicity assays assess cell death in culture but miss the complex, long-term processes of carcinogenesis.

Long-term cancer risk assessment relies on observing cancer development in animals, and the standard test used to classify a substance as a human carcinogen is a two-year rodent bioassay. In this study, rats and/or mice are exposed to various doses of the substance over a large portion of their lifespan, and researchers track tumor incidence across multiple organs. This direct evidence of cancer formation in a mammalian system provides the most relevant data for humans and is weighed together with any available human epidemiology.

Other tests have important roles but aren’t definitive for carcinogenicity. The Ames test screens for mutagenic potential in bacteria and can flag potential carcinogens, but mutagenicity does not always translate to human carcinogenicity. Acute toxicity tests focus on immediate lethal effects and do not address cancer risk, and in vitro cytotoxicity assays assess cell death in culture but miss the complex, long-term processes of carcinogenesis.